Gynecological Oncology Centre, Department of Obstetrics and Gynecology, First Faculty of Medicine and General University Hospital, Charles University, Prague, Czech Republic.
Gynecol Oncol. 2012 Mar;124(3):496-501. doi: 10.1016/j.ygyno.2011.11.037. Epub 2011 Nov 25.
Evaluate prognostic significance of low volume disease detected in sentinel nodes (SN) of patients with early stages cervical cancer. Although pathologic ultrastaging of SN allows for identification of low volume disease, including micro-metastasis and isolated tumor cells (ITC), in up to 15% of cases, prognostic significance of these findings is unknown.
A total of 645 records from 8 centers were retrospectively reviewed. Enrolled in our study were patients with early-stage cervical cancer who had undergone surgical treatment including SN biopsy followed by pelvic lymphadenectomy and pathologic ultrastaging of SN.
Macrometastasis, micrometastasis, and ITC were detected by SN ultrastaging in 14.7%, 10.1%, and 4.5% patients respectively. False negativity of SN ultrastaging reached 2.8%. The presence of ITC was not associated with significant risk, both for recurrence free survival and overall survival. Overall survival was significantly reduced in patients with macrometastasis and micrometastasis; hazard ratio for overall survival reached 6.85 (95% CI, 2.59-18.05) and 6.86 (95% CI, 2.09-22.61) respectively. Presence of micrometastasis was an independent prognostic factor for overall survival in a multivariable model.
Presence of micrometastasis in SN in patients with early stage cervical cancer was associated with significant reduction of overall survival, which was equivalent to patients with macrometastasis. No prognostic significance was found for ITC. These data highlight the importance of SN biopsy and pathologic ultrastaging for the management of cervical cancer.
评估早期宫颈癌前哨淋巴结(SN)中低容量疾病的预后意义。尽管 SN 的病理超分期允许识别多达 15%的病例中的低容量疾病,包括微转移和孤立肿瘤细胞(ITC),但这些发现的预后意义尚不清楚。
回顾性分析了 8 个中心的 645 份记录。本研究纳入了接受包括 SN 活检、盆腔淋巴结清扫术和 SN 病理超分期在内的手术治疗的早期宫颈癌患者。
SN 超分期检测到宏转移、微转移和 ITC 的患者比例分别为 14.7%、10.1%和 4.5%。SN 超分期的假阴性率为 2.8%。ITC 的存在与无复发生存和总生存均无显著风险相关。存在宏转移和微转移的患者总生存显著降低;总生存的风险比分别为 6.85(95%CI,2.59-18.05)和 6.86(95%CI,2.09-22.61)。在多变量模型中,微转移是总生存的独立预后因素。
早期宫颈癌患者 SN 中的微转移与总生存显著降低相关,与宏转移患者相当。ITC 无预后意义。这些数据强调了 SN 活检和病理超分期对宫颈癌管理的重要性。